# The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation

> **NCT00696982** · NA · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Diabetes Mellitus
- Arterial Stiffness

## Interventions

- **DRUG:** sitagliptin
- **DRUG:** glibenclamide

## Key facts

- **NCT ID:** NCT00696982
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2008-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696982, "The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00696982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*